Menu
  • Join
  • Login
  • Contact
 

Search abstracts


NICORANDIL IMPROVE PROGNOSIS OF CARDIAC ARREST PATIENT: A LARGE-SCALE MEDICAL INFORMATION ANALYSIS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: NIIMURA, Takahiro (Tokushima University Graduate School of Biomedical Sciences, Department of Clinical Pharmacology and Therapeutics, Japan)
  • Co-author(s): Takahiro Niimura: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Yoshito Zamami: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Yuki Izawa-Ishizawa: AWA Support Center, Tokushima University, Tokushima, Japan
    Mitsuhiro Goda : Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Keijo Fukushima: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Yuya Horinouchi: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
    Yasumasa Ikeda: Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
    Hiromichi Fujino: Department of Pharmacology for Life Sciences, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Koichiro Tsuchiya: Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Keisuke Ishizawa: Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan
  • Abstract:

    Background

    The survival rate of patients with cardiac arrest in Japan is around 10%. Because the main cause of poor survival prognosis is encephalopathy, development of a therapeutic drug for improving brain damage is desired. Nicorandil, a drug for the treatment of angina pectoris, has been reported to have a neuroprotective effect, but its effect ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 21 September 2019

FIP Congresses